GE HEALTHCARE TECHNOLOGIES INC.

NASDAQ: GEHC (GE HealthCare Technologies Inc.)

最近更新时间: 3天之前, 3:22AM

76.44

-1.52 (-1.95%)

前收盘价格 77.96
收盘价格 77.47
成交量 3,250,167
平均成交量 (3个月) 3,781,758
市值 34,899,599,360
市盈率 (P/E TTM) 15.66
预期市盈率 (P/E Forward) 16.50
价格/销量 (P/S) 1.75
股市价格/股市净资产 (P/B) 3.57
52周波幅
57.65 (-24%) — 94.80 (24%)
利润日期 29 Oct 2025
股息率 (DY TTM) 0.18%
营业毛利率 11.03%
营业利益率 (TTM) 14.78%
稀释每股收益 (EPS TTM) 4.76
季度收入增长率 (YOY) 2.70%
季度盈利增长率 (YOY) 50.80%
总债务/股东权益 (D/E MRQ) 97.51%
流动比率 (MRQ) 0.980
营业现金流 (OCF TTM) 1.78 B
杠杆自由现金流 (LFCF TTM) 1.58 B
资产报酬率 (ROA TTM) 5.87%
股东权益报酬率 (ROE TTM) 26.44%

市场趋势

短期 中期
行业 Health Information Services (US) 看涨 混合的
Health Information Services (全球的) 看涨 混合的
股票 GE HealthCare Technologies Inc. 看跌 看跌

AIStockmoo 评分

0.1
分析师共识 -0.5
内部交易活动 -3.0
价格波动 2.0
技术平均移动指标 0.0
技术振荡指标 2.0
平均 0.10

相关股票

股票 市值 DY P/E(TTM) P/B
GEHC 35 B 0.18% 15.66 3.57
TEM 13 B - 34.08 48.85
HQY 8 B - 56.36 3.71
WAY 7 B - 67.93 2.10
RCM 6 B - - 2.14
PRVA 3 B - 191.25 4.10

GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (54% of revenue), ultrasound (18%), patient care solutions (16%), and pharmaceutical diagnostics (12%). The company’s sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 44%, 26%, 14%, and 16% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (33% of revenue), pharmaceutical diagnostics (12%), and digital solutions (6%).

部门 Healthcare
行业 Health Information Services
投资方式 Mid Core
内部持股比例 0.28%
机构持股比例 80.26%
52周波幅
57.65 (-24%) — 94.80 (24%)
目标价格波幅
74.00 (-3%) — 93.00 (21%)
93.00 (Citigroup, 21.66%) 购买
83.50 (9.24%)
74.00 (Morgan Stanley, -3.19%) 保留
平均值 83.50 (9.24%)
总计 1 购买, 1 保留
平均价格@调整类型 71.32
公司 日期 目标价格 调整类型 价格@调整类型
Citigroup 31 Jul 2025 93.00 (21.66%) 购买 71.32
09 Jul 2025 89.00 (16.43%) 购买 75.51
Morgan Stanley 31 Jul 2025 74.00 (-3.19%) 保留 71.32

该时间范围内无数据。

日期 类型 细节
10 Sep 2025 公告 GE HealthCare announces intent to acquire icometrix to strengthen neurology portfolio with brain MRI assessment solutions
08 Sep 2025 公告 GE HealthCare Enters an Agreement to Distribute Flyrcado Through CDL Nuclear Technologies Group, a Leading Provider of Cardiac PET Imaging Equipment and Services in the U.S.
29 Aug 2025 公告 GE HealthCare unveils Vivid Pioneer, its most advanced AI-powered cardiovascular ultrasound system, designed to enhance speed and image quality for improved diagnostic confidence and workflow efficiency
28 Aug 2025 公告 GE HealthCare showcases integrated cardiology care pathway solutions and new AI-driven innovations at ESC 2025
21 Aug 2025 公告 GE HealthCare management to present at upcoming investor conferences
30 Jul 2025 公告 GE HealthCare reports second quarter 2025 financial results
29 Jul 2025 公告 AI Just Got a Green Light from the White House--Here's What That Means for Healthcare Stocks
24 Jul 2025 公告 GE HealthCare launches new advanced digital X-ray system to enable access and increase efficiency in high throughput settings
23 Jul 2025 公告 GE HealthCare drives growth with investment in AI-enabled medical devices and tops FDA’s list of AI authorizations for 4th Year with 100
07 Jul 2025 公告 GE HealthCare to announce second quarter 2025 results on July 30, 2025
01 Jul 2025 公告 GE HealthCare announces cash dividend for second quarter of 2025
24 Jun 2025 公告 FDA Approves Expanded Indications for GE HealthCare’s Vizamyl PET Imaging Agent for Beta Amyloid Detection, Enabling More Precise Care for Alzheimer’s Patients
23 Jun 2025 公告 GE HealthCare enhances cardiac diagnostics with innovative molecular imaging solutions showcased at SNMMI 2025
21 Jun 2025 公告 GE HealthCare drives innovation in theranostics with latest technological advances
20 Jun 2025 公告 AI Tools That Talk, Scan, and Save Lives Are Reshaping the Investment Landscape
19 Jun 2025 公告 Pioneering precision: GE HealthCare aims to elevate clinical care through total body PET/CT technology with Stanford Medicine
显示更多
股息率 (DY TTM) 0.18%
2年平均股息收益率 0.13%
股息支付比率 2.63%
预计下次股息支付 Feb 2026
除息日 公告日期 支付日期 详情
25 Jul 2025 01 Jul 2025 15 Aug 2025 0.035 现金
25 Apr 2025 27 Mar 2025 15 May 2025 0.035 现金
14 Jan 2025 21 Nov 2024 14 Feb 2025 0.035 现金
18 Oct 2024 18 Sep 2024 15 Nov 2024 0.03 现金
19 Jul 2024 26 Jun 2024 15 Aug 2024 0.03 现金
18 Apr 2024 22 Mar 2024 15 May 2024 0.03 现金
12 Jan 2024 08 Dec 2023 15 Feb 2024 0.03 现金
19 Oct 2023 22 Sep 2023 15 Nov 2023 0.03 现金
20 Jul 2023 23 Jun 2023 15 Aug 2023 0.03 现金
22 May 2023 25 Apr 2023 15 Jun 2023 0.03 现金

每年股息收益率

年份 每年总股息 ($) 频率/年份 收益率 %
2025 0.105 3 0.14
2024 0.120 4 0.15
2023 0.090 3 0.12

支撑、阻力和趋势线水平是由人工智能(AI)模型生成的,请谨慎解读。

投资组合

AI 建议策略模板

自定义的价格提醒

风险概况

| | | | |
很保守
适度保守
中等
中等风险
激进风险
安全边际 (EP)
部分利润 (TP1)
目标利润 (TP2)
最大损失 (SL)

免责声明:以上内容仅供参考,并非投资建议。请咨询合格的财务顾问。

开始购买价格 (EP)

第一个目标价格赚取利润 (TP1)

第二个目标价格赚取利润 (TP2)

停止损失价格 (SL)

52周波幅范围
 
52WL
 
52WH
SL
EP
TP1
TP2

所有提醒价格都在52周波幅范围内

已实现利润 -
未实现利润 -
收到股息 2025 -
利润总额 -
平均回报 -
数量(购买) -
平均价格(购买) -
数量(卖出) -
平均价格(卖出) -
没有符合您标准的股票